Note: Ingredients listed on restricted chemical lists
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
238-877-9
Name of the chemical
Talc: Hydrated magnesium silicate
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2020-05-07
Product name
HEPSERA TABLETS
Product Synonyms
HEPSERA TABLETS, 10 MG * ADEFOVIR DIPIVOXIL, FORMULATED PRODUCT
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended. Hazard summary Caution - Pharmaceutical agent. Prolonged exposure may cause chronic effects. Not classified for health hazards. However, occupational exposure to the mixture or substance(s) may cause adverse health effects. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
CROSCARMELLOSE SODIUM, MAGNESIUM STEARATE, Talc
Hazard pictograms
None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Prevention
Not available.
Response
Not available.
Storage
Not available.
Disposal
Not available.
Supplemental label elements
12 % of the mixture consists of component(s) of unknown acute oral toxicity. 93,34 % of the mixture consists of component(s) of unknown acute dermal toxicity. 100 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 100 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
